A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...

Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter publish ...

The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...

New research highlights nasal spray drug’s potential to counter Alzheimer’s by targeting brain enzyme dysfunction.

A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...

Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...

A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at Texas A&M University College of Medicine. Alzheimer's is the most common ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...

Nasacort 24HR Allergy Nasal Spray is the first product Dr. Randolph Betts, MD, a family medicine practitioner based in California, recommends for nasal congestion. He notes that almost all his ...

Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to ...